RDRahul Dubey

Rahul Dubey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rahul Dubey has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    IS TYPE 2 DIABETES MELLITUS AN INFLAMMATORY CONDITION? EXPLORING THE LINKS BETWEEN INTERLEUKIN-6, A PRO-INFLAMMATORY CYTOKINE, GLYCEMIC INDICES AND ADIPOSITY IN TYPE 2 DIABETES MELLITUS

    by Meghna Borah, Anju B. Teli, Rahul Dubey, Kalpajit Dutta, Rajib K. Bora, Debabani Bora

    Objective: The primary objective of our study was to evaluate the levels of inflammatory cytokine Interleukin-6 (IL-6) in diabetic patients and compare the levels with age and gender matched healthy controls. The secondary objective was to assess the correlation, if any, of IL-6 with glycemic indices and anthropometric markers of obesity. Methods: In this cross-sectional study, IL-6 levels were measured in 110 patients with T2DM and compared with an equal number of age-and gender-matched healthy controls. Correlations between interleukin-6 levels and glycemic markers and anthropometric measurements were assessed. Results: Interleukin-6 levels were significantly elevated in diabetic patients, with a sixfold increase compared to healthy controls. In the diabetic group, the mean IL-6 levels were found to be 12.24±4.18 pg/ml as compared to 2.01±0.82 mg/dl in healthy controls. The elevation was more pronounced in obese patients (seven-fold increase) with a mean value 13.8±4.5 pg/ml, compared to their non-obese counterparts (five. five-fold increase) with a mean value of 11.1±3.8 pg/ml. A moderate positive correlation was observed between IL-6 and BMI (r = 0.31), and a stronger positive correlation was found between IL-6 and HbA1c (r = 0.70). Conclusion: Our findings confirm that IL-6 is significantly elevated in T2DM patients, with higher levels observed in those with obesity. These results support the hypothesis that inflammation plays a crucial role in the pathogenesis of T2DM, particularly in the context of obesity, and emphasize the potential of targeting inflammatory pathways as a therapeutic strategy.

  • Open Access

    Vitamin D levels and tumor necrosis factor-α activity in newly diagnosed patients with type 2 diabetes mellitus: An exploratory study in North-East India

    by Rahul Dubey, Anju Barhoi Teli, Uttam Kumar Nath, Bharati Devi, Anuradha Hazarika Medhi, Dharma Rao Vanamali

    Background: Diabetes poses a global threat, leading to hospitalizations and premature death if not managed properly. It involves tumor necrosis factor-α (TNF-α), an inflammatory cytokine, which binds to TNF-α receptor-1, triggering sphingomyelinase, and ceramide production. Vitamin D acts as an anti-inflammatory agent, reducing inflammatory cytokines and proinflammatory cell growth, and benefiting diabetes mellitus (DM). Aims and Objectives: The primary objective was to compare serum Vitamin D and TNF-α levels in diabetics and non-diabetics. The secondary objective was to explore Vitamin D and TNF-α correlation in newly diagnosed type 2 diabetes. Materials and Methods: A case–control study involved 92 subjects in each group. Data included demographics, clinical assessments, glycemic parameters, Vitamin D, and TNF-α. Statistical analysis used student’s t-test and Pearson correlation (P<0.05). Results: The cohort comprised 34 females (36.96%) and 58 males (63.04%). Cases had significantly higher glycemic levels: FBG (247.2±53.92 mg/dL vs. 91.45±16.64 mg/dL), postprandial plasma glucose (319.7±72.08 mg/dL vs. 111.3±21.76 mg/dL), and glycated hemoglobin (HbA1c) (10.39±2.41% vs. 5.43±0.48%). Mean serum Vitamin D in cases (22.63 ng/mL) was significantly lower than controls (58.15 ng/mL), and mean TNF-α in cases (5.01 pg/mL) was higher than controls (4.63 pg/mL, P<0.0001). HbA1c negatively correlated with serum Vitamin D (r=−0.7461) and positively with TNF-α (r=0.7831). Vitamin D correlated negatively with TNF-α (r=−0.6481). Conclusion: The study revealed lower serum Vitamin D and higher TNF-α levels in cases, with a significant inverse association. It also found an inverse link between Vitamin D and HbA1c and a strong positive correlation between HbA1c and TNF-α. Recognizing Vitamin D and TNF-α’s diagnostic significance promises innovative strategies for managing type 2 DM.